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To identify genetic determinants of single-cell heterogeneity, we first identified a reporter of heterogeneity that was relevant to antibiotic efficacy appropriate for a genetic screen. Calcein AM is a non-fluorescent hydrophobic molecule that enters cells through passive diffusion. Once inside, calcein AM is cleaved by esterases to produce calcein, a charged fluorescent molecule that is trapped in the cytoplasm unless exported through active mechanisms 4 . Both molecules are substrates for ABC transporters in eukaryotic cells 5, 6 . Therefore, we hypothesized that: (1) cells would not stain uniformly because of differences in uptake, esterase activity, and efflux; and (2) these differences between cells would account, in part, for differences in antibiotic susceptibility. When we stained a population of Mycobacterium smegmatis cells we saw heterogeneous fluorescence by flow cytometry spanning two orders of magnitude (Fig. 1a) . By time-lapse microscopy we found that much of this heterogeneity appeared to begin at the time of cell division (Supplementary Video 1). Daughter cells accumulated calcein unevenly, although the calcein intensity before division was uniform throughout the mother cell. The daughter cell that inherited the new pole from the previous round of division was consistently brighter than its sister cell, which inherited the old pole (Fig. 1b) . To test whether heterogeneity in calcein accumulation could explain the variation in response to certain drugs, we used time-lapse microscopy and microfluidics to determine whether calcein fluorescence of individual cells before drug treatment correlated to survival after treatment with the antibiotic rifampicin, a first-line drug for tuberculosis (Fig. 1c) . We found that bright cells were less likely to divide following antibiotic treatment than dim cells (Fig. 1d) . Thus, calcein accumulation predicts susceptibility to rifampicin on a single-cell level.
To determine the mechanism underlying the variability in calcein staining, we designed a genetic screen to identify transposon mutants with altered calcein accumulation. We hypothesized that there could be two different types of mutations-those that altered the average behaviour of the population and those that changed the variation of the population. To detect each of these, we designed a FACS-based screen that would identify alterations in both the median and distribution of calcein staining in M. smegmatis transposon mutants 7 (Fig. 2a ). After staining with calcein, we used FACS to sort cells into eight bins, each representing around 12.5% of the population (Fig. 2b ) and used deep sequencing to quantify transposon insertions per gene in each bin (Fig. 2c) . Using the total insertions in the entire population, we calculated the effective fluorescence distribution for each gene as compared to wild type (Fig. 2d) .
We found many mutations that affected the average fluorescence (Fig. 2e, Supplementary Table 1 ). Several of these were in genes involved in transport/permeability across the membrane. For example, among those with higher fluorescence, we found insertions in an operon that encodes two putative efflux pumps (msmeg5660-5659) and enzymes required for the modification of mycolic acids that constitute a major . b, Wild-type cells were imaged over time in a microfluidic device while calcein AM was continuously added. At the time of cell division, the average calcein intensity of each daughter cell was measured. For 58 sister cell pairs, the ratio of the average calcein intensity of the new pole sister to the average calcein intensity of the old pole sister is calculated. c, d, Using the experiment outlined in c, the fluorescence of 96 individual cells is measured and compared to the number of progeny that same cell produced during and after rifampicin treatment, shown in d.
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portion of the cell wall (umaA). Likewise, we found that insertions in mspA, a gene that encodes a well-characterized porin known to permit entry of molecules through the M. smegmatis cell wall, resulted in lower median fluorescence 8 . We constructed targeted deletions 9 for several genes (Supplementary Table 2 ) and found that all had the predicted phenotypes (Fig. 3a, Extended Data Fig. 1a) .
We expected that some, but not all, mutants would have altered killing by rifampicin. Indeed, we found mutations that might alter rifampicin accumulation substantially changed antibiotic susceptibility, either positively (Δ umaA, Δ tetR, Δ mmpS3) or negatively (Δ mspA, Δ lepA), whereas others that encode predicted esterases, enzymes that may cleave calcein AM (Δ msmeg_2500 and Δ caeA), did not alter rifampicin killing in the predicted fashion (Extended Data Fig. 1b) . Thus, our mutational data strongly suggest that calcein AM fluorescence correlates with the single-cell accumulation of rifampicin.
In addition to having an altered average fluorescence, several of the gene-deletion strains also had a different degree of cell-to-cell variation (Fig. 3b) . The most notable difference was observed with Δ mspA, which had a fluorescent distribution that was both broader and decreased in average. By contrast, two others-Δ mmpS3 and Δ msmeg5660-5659-produced both an increase in fluorescence and a narrowing of the distribution by both flow (Fig. 3b) and microscopy (for Δ mmpS3) (Extended Data Fig. 1c) .
Heterogeneity in drug susceptibility has typically been studied in subpopulations of non-growing cells that are refractory to antibiotic treatment 10 . In time-kill curves this manifests as a biphasic curve, indicating two distinct subpopulations 11 . We hypothesized that the loss of heterogeneity in calcein (and, by proxy, drug) accumulation, would also lead to a difference in killing of the population. Indeed, by timelapse microscopy, we observed that at drug concentrations close to the minimum inhibitory concentration (MIC) (Extended Data Table 1 ), some cells stopped growing or died whereas others continued to grow in the presence of drug. The growing subpopulation itself produced variable daughters: those that grew and those that did not, indicating a lack of heritability (Extended Data Fig. 2a, Supplementary Video 2) .
We thus hypothesized that in a wild-type population of M. smegmatis cells, there were multiple subpopulations, each with a different effective MIC. Furthermore, a less-variable mutant population would result in a more 'all or nothing' phenotype in response to different concentrations of drug (Fig. 3c) . To test this, we measured cell growth at different sub-inhibitory drug concentrations (Extended Data Fig. 2b ). We reasoned that the growth of the bulk population at a fixed time is proportional to the percentage of growing cells in the population and their individual growth rates. To assess variability in the population, we fit the data to a sigmoid curve and calculated the slope; a steeper slope is associated with less variability. We then compared the two mutants Δ mmpS3 and Δ umaA. Both accumulated approximately twice the average amount of calcein as a wild-type population (Fig. 3a) , but one varied less (Δ mmpS3), and the other more (Δ umaA) as compared to wild type (Fig. 3b) . Consistent with our hypothesis, the slope was steeper for Δ mmpS3 and shallower for Δ umaA than wild type ( Fig. 3d ) and correlated extremely well with the measured calcein CV for the three strains tested (Fig. 3e) . Consistently, by time-lapse microscopy, nearly all Δ mmpS3 cells stopped growing at drug concentrations that allowed for growth of a subpopulation of wild-type cells (Supplementary Video 2). Likewise, at drug concentrations normalized to the average calcein accumulation of each strain to correct for the intracellular accumulation of rifampicin, Δ mmpS3 survival decreased whereas the more variable Δ umaA strain had increased survival compared to wild type (Extended Data Fig. 2c ). Together, these data suggest that Δ mmpS3 both accumulates drug more homogenously and is more uniformly susceptible to rifampicin than a wild-type population. We renamed mmpS3 as lamA (loss of asymmetry mutant A).
lamA is a previously uncharacterized gene. Although the protein product shares limited homology to the four other mmpS genes in the M. tuberculosis genome (Extended Data Fig. 3a) , it is distinctly different from the others (Extended Data Fig. 3b ). It is over twofold larger and is the only mmpS homologue that is not in an operon with an mmpL gene. lamA homologues are found across mycobacterial species 12 , including in the minimal genome of M. leprae, but not in other organisms.
How does lamA create and maintain heterogeneity in a population of genetically identical M. smegmatis cells? Consistent with our observation in Fig. 1b , at the time of division, the asymmetry in daughter cell accumulation of calcein in Δ lamA cells was much reduced (by approximately 60%) (Fig. 3f, Supplementary Video 3) . As a result, we hypothesized that LamA was involved in some aspect of mycobacterial cell growth and/or division. Below are cartoons of potential distributions that are analogous to an effective fluorescent distribution for a single mutant. e, For each gene or intergenic region, the mean of the effective fluorescent distribution is determined and plotted against a Mann-Whitney U-test P value, which is derived from comparing the distribution of each gene to a calculated wild-type (WT) distribution. We picked nine genes (shown in red) and made eight genedeletion strains (Supplementary Table 2 ).
In contrast to rod-shaped bacteria that insert cell wall material along their sidewalls, mycobacteria insert new cell wall at or near their poles 13 . Under our growth conditions, polar growth is asymmetric: for a single cell, the new pole grows less over the course of the division cycle, than the old pole 2
. Surprisingly, loss of lamA changes this pattern of growth. In Δ lamA cells, new cell wall material is added at more similar rates between the old and new poles (Fig. 4a, Extended Data  Fig. 4a, b) , although the overall growth of individual cells (Extended Data  Fig. 4a, c, d ) and the population (Extended Data Fig. 4e, f) is the same as wild-type cells. Thus, lamA is at least partially responsible for asymmetric polar growth in mycobacteria.
The molecular details of cell growth and division in mycobacteria are poorly understood as compared to other rod-shaped bacteria. Mycobacteria do not encode obvious homologues of many cell elongation and division factors 13 . Therefore, to further understand lamAmediated asymmetric growth, we visualized the two best-characterized factors in the division and elongation complexes, FtsZ and Wag31 (DivIVA), in wild-type and mutant cells. FtsZ and Wag31 localize early to the site of division or elongation, respectively, and recruit other factors into active complexes. In cells that expressed FtsZ-mCherry2B and eGFP-Wag31, by time-lapse microscopy, we observed dynamic changes in the localization of each of these proteins in the absence of lamA during the transition between division and growth at the new pole. The division complex, as defined by FtsZ-mCherry2B, more rapidly decreased at the end of the cell cycle (Extended Data Fig. 5a-d , Supplementary Videos 4 and 5), whereas the elongation complex, as defined by eGFP-Wag31, was recruited more rapidly to the site of division and, thus, to the site of the new pole (Extended Data Fig. 5a , c, d, Supplementary Videos 6 and 7). These data suggest that LamA functions at the site of division, during the switch between division and elongation. Indeed, a GFPmut3-LamA (ref. 14) fusion protein localizes to the septum (Fig. 4b) at the same time that FtsZ-mCherry2B becomes stabilized in wild-type cells (Extended Data Figs 5a, b, Supplementary Video 8).
Therefore, we hypothesized that LamA is a member of the mycobacterial division complex (the 'divisome') that inhibits polar growth at the nascent new pole. To test whether LamA is a member of the division complex, we immunoprecipitated an epitope-tagged LamA and identified co-precipitating proteins using mass spectrometry. We found three unique peptides corresponding to PonA1, but none was present in a control sample that lacked the epitope tag (Supplementary Table 5 ). PonA1 is the major peptidoglycan-synthesizing enzyme in mycobacteria and is known to be a member of the division complex and an early member of the elongation complex 15 . To verify this interaction, we constructed a strain that expressed lamA and ponA1, each tagged with a distinct epitope. We found that LamA could be precipitated with an antibody directed against the PonA1 epitope (Fig. 4c) only in the presence of epitope-tagged PonA1.
To test whether LamA inhibits cell wall synthesis, we overexpressed LamA using an inducible promoter on a multi-copy plasmid. Almost immediately after induction, we observed that, on average, cells added less cell wall material between successive generations (Extended Data  Fig. 6a, Supplementary Video 9) suggesting that, indeed, LamA inhibits cell wall synthesis. Furthermore, as we followed individual cells over LETTER RESEARCH several generations, we observed that not all induced cells behaved in the same way. Cells with the oldest poles-poles that were established before inducer was added-were almost unaffected by the addition of the inducer, whereas cells with the newest poles-poles that were assembled in the presence of inducer-were the smallest in the later generations (Extended Data Fig. 6b ). These data support the hypothesis that LamA is a member of the mycobacterial divisome and inhibits cell wall synthesis at the nascent new pole.
Because Δ lamA cells have decreased size and growth rate heterogeneity, we hypothesized that they should be killed at a more uniform rate by drugs that target the cell wall. Indeed, Δ lamA M. smegmatis cells bound fluorescently conjugated vancomycin more uniformly (Extended Data Fig. 7a ), and were killed more rapidly by vancomycin, teicoplanin and certain β -lactams (Extended Data Fig. 7b-e) . As with rifampicin, a subpopulation of wild-type M. smegmatis cells was able to grow and divide in the presence of vancomycin. In fact, wild-type M. smegmatis cells were able to grow even at vancomycin concentrations above the MIC (Supplementary Video 10) and, thus, as has been previously observed with other antibiotics in mycobacteria 16 , the bacterial number in the presence of drug, as measured by outgrowth on agar plates, reflects a balance of growing and non-growing or dead cells. In a Δ lamA strain, this heterogeneity is markedly reduced as measured by growth of the population as a function of drug concentration (Extended Data Fig. 7f ) and by time-lapse microscopy (Supplementary Video 10) . Thus, LamA may be an attractive drug target for pathogenic mycobacterial species. In fact, M. tuberculosis cells that lacked lamA were killed more rapidly than wild-type or complemented cells by vancomycin and rifampicin (Fig. 4d) .
To determine how the amount of LamA-mediated heterogeneity compares to other organisms, we measured the length of cells just before division. We found that the amount of variation in wild-type M. smegmatis cells (19%) is much higher than Δ lamA M. smegmatis cells (12%) (Fig. 4e) and other rod-shaped bacteria 17, 18 , including Corynebacterium glutamicum (Extended Data Fig. 8) , a close relative of mycobacteria with similar cell wall architecture and polar elongation but that does not encode LamA. Importantly, this loss of heterogeneity could be restored in Δ lamA cells by complementation with lamA (Extended Data Fig. 9) .
Together, these data show that LamA is a member of the mycobacterial division complex. It functions to inhibit cell wall synthesis at the new pole during the switch between division and elongation. Consequently, asymmetric growth is established between the new and old poles, which in turn leads to a more heterogeneous population of cells. Reducing heterogeneity in pathogen populations could decrease the rate of treatment failure. For example, some compounds subvert variability in HIV populations 19 . In M. tuberculosis, targeting LamA could lead to synergistic therapies that shorten treatment duration and increase the rate of cure.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. rifampicin or 4 μ g ml −1 vancomycin for three biological replicates. (Dotted line represents limit of detection; * P < 0.05, Student's t-test in comparison to wild type.) e, The distribution for the length of cells just before division (mother cells) for wild-type (n = 120) and Δ lamA (n = 120) cells. * * * * P < 0.0001, two-sided Student's t-test with Welch's correction to compare either mean (a) or variation (e).

METHODS
Bacterial strains and culture conditions. Mycobacterium smegmatis MC2 155 was grown in 7H9 salts (Becto-Dickinson) supplemented with: 5 g l −1 albumin, 2 g l −1
dextrose, 0.85 g l −1 NaCl, 0.003 g l −1 catalase, 0.2% glycerol and 0.05% Tween80, or plated on LB agar. M. tuberculosis H37Rv was cultured in Middlebrook 7H9 salts supplemented with OADC (oleic acid, albumin, dextrose, catalase (BD Biosciences)), 0.25% glycerol, and 0.05% Tween-80 or plated on 7H10 agar. E. coli DH5α was used for cloning. Antibiotic concentrations used for M. smegmatis and M. tuberculosis were: 25 μ g ml −1 kanamycin, 20 μ g ml −1 zeocin, and 50 μ g ml
hygromycin. Antibiotic concentrations for E. coli were: 50 μ g ml −1 kanamycin and 100 μ g ml −1 hygromycin. All strains were grown at 37 °C. Coryne glutamicum was grown in Brain-Heart Infusion Broth. Strain construction. All knockouts were made using recombineering 9 . In M. smegmatis, the genes in Supplementary Table 2 were replaced with a zeocin resistance cassette, surrounded by loxP sites. Constructs were designed to be assembled into a pUC57 vector by isothermal assembly. Primers are listed in Supplementary Table 3 : homology to M. smegmatis genome shown in lowercase; homology to pUC57 vector (upper primer for each gene) and zeocin resistence cassette (lower primer for each gene) shown in uppercase. For the M. tuberculosis knockout, a construct was synthesized comprised of 500 bp of homology (shown in Supplementary Table 3 ) surrounding a HygR cassette and loxP sites. For genes in operons, internal-gene deletions were made. The complementing strains were made by amplifying lamA (MSMEG_4265 or Rv2198c) with 300 bp of the sequence upstream of the gene (primers listed in Supplementary Table 4) to capture the native promoter. These were assembled into a KanR plasmid and integrated in single copy at the L5 phage integration side. The fluorescent protein fusions: ftsZ-mcherry2B, eGFP-wag31 were expressed under a medium-strength promoter ('ptb21'); lamA-GFPmut3 was constructed using the pUV15 promoter. Each was integrated into the M. smegmatis chromosome at phage integration sites (L5 for eGFP-wag31 and GFPmut3-lamA; tweety (tw) for ftsZ-mcherry2B) 20 as merodiploids. To test the interaction between PonA1 and LamA constructs were made in which lamA and/or ponA1, both under the pUV15 promoter, were integrated onto the chromosome at different phage integrate sites (L5 for ponA1 (ref. 15) , tweety for lamA). To make the inducible overexpression strain, LamA was sub-cloned into a multi-copy, episomal vector carrying both the tet operator and the tet repressor. Flow cytometry. Mid-log-phase cultures were stained with 0.5 μ g ml −1 calcein for 1 h and then filtered through a 10-μ m filter. These cells were then analysed by flow cytometry (MACSQuant VYB excitation: 488 nm; emission filter: 525/50). To determine the appropriate gates for single cells, a pilot experiment was performed in which equal numbers of RFP-and GFP-expressing cells were grown together overnight. This mixed population, as well as the single-colour-expressing strains, were taken to the flow cytometer and the settings for FSC, SSC, and cell density were adjusted to minimize the dual RFP/GFP population. After adjustment and gating the dual population accounted for around 1% of the population. These setting and gates was then used for all subsequent experiments. Time-lapse fluorescence microscopy. For all experiments, except that shown in Fig. 1c , time-lapse fluorescence microscopy was performed on an inverted Nikon TI-E microscope equipped with an environmental chamber that was maintained at 37 °C. Cells were imaged every 15 min for 15-20 h in a B04A Microfluidic bacteria plate (CellASIC) continuously perfused with 7H9 medium. At the appropriate time 7H9 media with 1 μ g ml −1 calcein was added automatically by the CellASIC system. For the experiment shown in Fig. 1b, imaging . To assess polar growth, an aminereactive dye was used for pulse-chase experiments as described in ref.
2. The analysis of these images was performed in a semi-automated fashion: first, single-cells were identified manually on the phase image and marked using a segmented line that was drawn consistently from the new pole to the old pole. Then, a custom Fiji script was run to measure and save the corresponding fluorescence line profile. These profiles were imported into MATLAB where the minimum, maximum, and half-maximum fluorescence intensity was determined. The half-maximum intensity was used as the consistent measurement to determine where the amine-reactive dye was in relation to the tip of the pole. Finally, these measurements were used to determine polar and total growth over the course of a cell cycle. In all experiments, division/septation was determined by a visible invagination on the phase image FACS transposon screen. An M. smegmatis transposon mutant library was thawed, grown overnight to mid-log phase, and then stained with 0.5 μ g ml −1 calcein for 1.5 h. They were then centrifuged and half the supernatant was taken out and discarded. The re-suspended pellet was passed through a 10-μ m filter and taken to the FACS instrument (FACSAria; excitation: 488 nm; emission filter: 530/30) where 8 bins were drawn across the population, each representing 12.5% of the population. 150,000 cells per bin were sorted into 7H9 and then directly plated on LB Agar containing kanamycin. Transposon sequencing, mapping, counting insertions, and analysis. Genomic DNA (gDNA) was collected from the transposon libraries and prepared for PCR amplification as described in ref. 22 . PCR-amplified transposon-gDNA junctions were then subjected to high-throughput sequencing using the MiSeq platform as per manufacturer's instructions.
gDNA-transposon junctions were mapped on the M. smegmatis genome and counted as described in ref. 22 . The reads at each TA dinucleotide site for each bin where then imported into Matlab where they were processed by a custom Matlab program. The reads were normalized in a number of ways. First, they were normalized to the total number of reads in each sequenced library. Then, the data was normalized to a normal distribution, which was necessary as each bin represented 12.5% of the total population and therefore represented a different area under a normal distribution curve (refer to Fig. 2b) . We then created an effective fluorescent distribution for each gene by normalizing the reads for each bin for a particular gene to the total number of pre-normalized reads for that gene. Lastly, to determine significance, we used the fact that we knew how many cells we had sorted, and therefore approximately how many cells N we had sorted which had a transposon in a particular gene. We 'lightly simulated' N number of cells to have the effective distribution for each gene we calculated above and compared this distribution to an effective wild-type distribution that we created from the median values across all genes for both N and fluorescence using a Mann-Whitney test (to determine whether the median was significantly different). Immunoprecipitation and western blotting. 100 ml of M. smegmatis culture was grown to mid-log phase, washed twice with PBS + 0.05% tween (PBS-T), and re-suspended in 1 ml of PBS-T. The crosslinker SDAD was added to the cells to a final concentration of 2 mM and incubated at room temperature for 10 min. 11 μ l of 1 M Tris was added to stop the reaction, and incubated 5 min at room temperature. 333 μ l of culture was then added to a well in a 6-well glass bottomed plate, and irradiated with UV light (365 nm) for 15 min. The cells were then recovered from the well, spun down and resupsended in 1 ml of Buffer W (100 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA) + protease inhibitors. This was then split between two tubes with glass beads and beads were beat 8 times for 1 min each, icing in between. For pulldowns using streptactin, SDS was added to the lysate (final concentration of 1%), and then was pre-cleared of endogenously biotinylated proteins using avidin agarose for 1 h at room temperature. This was then spun down and the supernatant was added to beads coated with streptactin, and incubated for 30 min at room temperature. The beads were washed three times with Buffer W + 1% SDS, and eluted using 50 μ l buffer containing 10 mM biotin. For experiments using anti-Flag beads, all steps were the same except for the addition of SDS, the pre-clearing with avidin, and the elution was carried out with Flag peptide. Survival measurements. Strains were grown to mid-log phase, diluted to OD 0.05 in triplicate, and treated with the indicated antibiotic in 7H9 and incubated with shaking at 37 °C. Drugs were added once at the beginning of the experiment. Cultures were treated in culture tubes or ink wells. A small volume of cells was taken out at the specified time point, serially diluted, and plated for survivors by colony-forming units. Each of the M. smegmatis time-kill curves was performed at least twice, each time in triplicate, with similar results. The rifampicin kill curve in M. tuberculosis was performed twice-once in duplicate and then again in triplicate (this one is shown in Fig. 4d )-with similar results, whereas the M. tuberculosis vancomycin time-kill curve was performed twice at two different vancomycin concentrations with similar results. OD 600 nm measurements. Strains were grown to mid-log phase, diluted to OD 0.2 in triplicate (or duplicate for Fig. 3c to measure all three stains on the same 96-well plate). Water was added to the outermost wells of a 96-well plate. Two-fold serial dilutions of the appropriate drug were added to inner wells of the plate. Both a no-bacteria control and a no-drug control were included. Cells were added for a final OD of 0.1. This was incubated at 37 °C with shaking in a Tecan 200 plate reader, and optical density measurements at 600 nm were measured automatically every 30 min for approximately 18 h. The optical density of the wells exposed to drug were background subtracted and divided by the no-drug control. MIC determination. The MIC of M. smegmatis and M. tuberculosis strains were performed using the Alamar Blue assay as described in ref. 15 . Statistical analysis. All experiments were performed at least twice, unless otherwise noted. Means were compared using a two-sided Student's t-test. In the cases where sample variances differed we used Welch's correction, which does not assume equal variances, to compare the average and/or variation of two samples. For the data shown in Fig. 2e , we used a non-parametric test (Mann-Whitney), as some genes displayed non-normal distributions. P < 0.05 was considered significant. For most microscopy experiments, roughly 100 cells were analysed (or 50 sister cell pairs). For experiments that followed cells over shorter time increments,
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approximately 20 cells were analysed. For ratios, as in Fig. 3 and Extended Data Fig. 1 , error in the ratio (in terms of standard deviation) was calculated assuming independence in the two measurements. No statistical methods were used to predetermine sample size, and the researchers were not blinded to sample identity. Data availability. Source Data and Supplementary Information are provided in the online version of the paper. All other data that support the findings of this study are available from the corresponding author(s) upon reasonable request. 
